Picture of Corline Biomedical AB logo

CLBIO — Corline Biomedical AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Corline Biomedical Potential Customer In USA Ceases Ops

Aug 18 (Reuters) - Corline Biomedical AB  CLBIO.ST :
    * POTENTIAL CUSTOMER IN USA CEASES OPERATIONS
    * IN 2021, CORLINE SIGNED TERM SHEET WITH SMALLER CALIFORNIA-BASED COMPANY FOR CHS
MODIFICATION OF
IMPLANTS BEING DEVELOPED FOR TREATMENT OF VENOUS INSUFFICIENCY
    * FUTURE POTENTIAL WAS STATED TO BE SEK 50 MILLION IN ANNUAL REVENUE
    * HAS NOW RECEIVED INFORMATION THAT BOARD OF DIRECTORS OF CUSTOMER COMPANY VOTED TO DISSOLVE
COMPANY'S OPERATIONS AS MAIN INVESTORS DO NOT BELIEVE THEY HAVE SUFFICIENT CAPITAL TO SUPPORT
BUSINESS
    * THUS, TERM SHEET CEASES TO APPLY AND CORLINE IS WRITING OFF FUTURE EARNINGS POTENTIAL

Source text for Eikon:  ID:nGNE2c8ZWF 
Further company coverage:  CLBIO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Corline Biomedical AB

See all news